Human medicines European public assessment report (EPAR): Vaxelis, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed), Date of authorisation: 15/02/2016, Revision: 17, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Rhiniseng, inactivated vaccine to prevent progressive and non-progressive atrophic rhinitis in pigs, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Rexxolide, tulathromycin, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Respiporc FLUpan H1N1, porcine influenza vaccine (inactivated), Status: Authorised

EMEA-001556-PIP02-24

Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 4, Status: Authorised

Guide on access to unpublished documents

Veterinary medicines European public assessment report (EPAR): Quadrisol, vedaprofen, Status: Authorised

Human medicines European public assessment report (EPAR): Okedi, risperidone, Date of authorisation: 14/02/2022, Revision: 4, Status: Authorised

Pool of patient and consumer experts: list for 2024-2029